$PRSO
Peraso Inc.

2021 Q2 Form 10-Q Financial Statement

#000156459021043817 Filed on August 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $697.0K $1.968M
YoY Change -64.58% -35.81%
Cost Of Revenue $435.0K $604.0K
YoY Change -27.98% -50.81%
Gross Profit $262.0K $1.364M
YoY Change -80.79% -25.79%
Gross Profit Margin 37.59% 69.31%
Selling, General & Admin $1.799M $964.0K
YoY Change 86.62% 3.43%
% of Gross Profit 686.64% 70.67%
Research & Development $2.892M $985.0K
YoY Change 193.6% 0.41%
% of Gross Profit 1103.82% 72.21%
Depreciation & Amortization $515.0K $40.00K
YoY Change 1187.5% 0.0%
% of Gross Profit 196.56% 2.93%
Operating Expenses $4.691M $1.949M
YoY Change 140.69% 1.88%
Operating Profit -$4.429M -$585.0K
YoY Change 657.09% 680.0%
Interest Expense $786.0K $56.00K
YoY Change 1303.57% 0.0%
% of Operating Profit
Other Income/Expense, Net -$215.0K $2.000K
YoY Change -10850.0% -92.86%
Pretax Income -$5.430M -$640.0K
YoY Change 748.44% 521.36%
Income Tax
% Of Pretax Income
Net Earnings -$5.430M -$639.0K
YoY Change 749.77% 520.39%
Net Earnings / Revenue -779.05% -32.47%
Basic Earnings Per Share -$1.03
Diluted Earnings Per Share -$1.03 -$0.32
COMMON SHARES
Basic Shares Outstanding 5.251M
Diluted Shares Outstanding 5.251M

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.57M $7.400M
YoY Change 164.41% 0.0%
Cash & Equivalents $2.040M $7.375M
Short-Term Investments $6.091M
Other Short-Term Assets $388.0K $300.0K
YoY Change 29.33% -66.67%
Inventory $1.026M $1.000M
Prepaid Expenses
Receivables $632.0K $600.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $21.61M $9.300M
YoY Change 132.39% -10.09%
LONG-TERM ASSETS
Property, Plant & Equipment $301.0K $200.0K
YoY Change 50.5% -10.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.484M
YoY Change
Other Assets $17.00K $0.00
YoY Change -100.0%
Total Long-Term Assets $3.802M $200.0K
YoY Change 1801.0% -82.65%
TOTAL ASSETS
Total Short-Term Assets $21.61M $9.300M
Total Long-Term Assets $3.802M $200.0K
Total Assets $25.41M $9.500M
YoY Change 167.52% -17.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $89.00K $0.00
YoY Change -100.0%
Accrued Expenses $1.350M $1.400M
YoY Change -3.57% 25.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $200.0K
YoY Change -100.0%
Total Short-Term Liabilities $1.787M $1.600M
YoY Change 11.69% 6.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $3.400M
YoY Change -100.0% 25.93%
Other Long-Term Liabilities $10.00K
YoY Change
Total Long-Term Liabilities $10.00K $3.400M
YoY Change -99.71% 21.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.787M $1.600M
Total Long-Term Liabilities $10.00K $3.400M
Total Liabilities $1.797M $5.000M
YoY Change -64.06% 15.79%
SHAREHOLDERS EQUITY
Retained Earnings -$245.2M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$11.16M $4.546M
YoY Change
Total Liabilities & Shareholders Equity $25.41M $9.500M
YoY Change 167.52% -17.37%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$5.430M -$639.0K
YoY Change 749.77% 520.39%
Depreciation, Depletion And Amortization $515.0K $40.00K
YoY Change 1187.5% 0.0%
Cash From Operating Activities -$4.638M -$460.0K
YoY Change 908.26% -141.07%
INVESTING ACTIVITIES
Capital Expenditures -$145.0K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $1.611M $0.00
YoY Change -100.0%
Cash From Investing Activities $1.466M $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $12.00M $1.600M
YoY Change 650.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -139.0K 2.200M
YoY Change -106.32%
NET CHANGE
Cash From Operating Activities -4.638M -460.0K
Cash From Investing Activities 1.466M 0.000
Cash From Financing Activities -139.0K 2.200M
Net Change In Cash -3.311M 1.740M
YoY Change -290.29% 8.07%
FREE CASH FLOW
Cash From Operating Activities -$4.638M -$460.0K
Capital Expenditures -$145.0K $0.00
Free Cash Flow -$4.493M -$460.0K
YoY Change 876.74% -141.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3228000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1134000
us-gaap Gross Profit
GrossProfit
2094000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1946000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
964000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2099000
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
3484000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
121000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
303000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17000
CY2020Q4 us-gaap Assets
Assets
8298000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
76000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1350000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1300000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2506000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
201000
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
244000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-245193000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25414000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Gross Profit
GrossProfit
1364000
us-gaap Gross Profit
GrossProfit
1567000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8660000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8660000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
23617000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1968000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
604000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
939000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
985000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2381000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2358000
us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
392000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2436000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.88
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2780000
CY2021Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-3000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-4000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2578000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2436000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2932000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2478000
CY2021Q1 mosy Stock Issued During Period Value Issuance Of Common Stock For Payment Of Accrued Interest
StockIssuedDuringPeriodValueIssuanceOfCommonStockForPaymentOfAccruedInterest
140000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6817000
CY2021Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11063000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1696000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11969000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
97000
CY2021Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-3000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1205000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
23617000
CY2020Q1 mosy Stock Issued During Period Value Stock Awards
StockIssuedDuringPeriodValueStockAwards
-1000
CY2020Q1 mosy Exercise Of Pre Funded Warrants Value
ExerciseOfPreFundedWarrantsValue
2000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
68000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
3500000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1619000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
66000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-639000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
4546000
us-gaap Profit Loss
ProfitLoss
-2574000
us-gaap Profit Loss
ProfitLoss
-2044000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
36000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
82000
us-gaap Share Based Compensation
ShareBasedCompensation
165000
us-gaap Share Based Compensation
ShareBasedCompensation
134000
us-gaap Paid In Kind Interest
PaidInKindInterest
30000
us-gaap Paid In Kind Interest
PaidInKindInterest
112000
mosy Amortization Of Lease Right Of Use Asset
AmortizationOfLeaseRightOfUseAsset
98000
mosy Amortization Of Lease Right Of Use Asset
AmortizationOfLeaseRightOfUseAsset
43000
mosy Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-93000
mosy Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-50000
mosy Gain Loss On Settlement Of Convertible Notes Payable And Accrued Interest Net
GainLossOnSettlementOfConvertibleNotesPayableAndAccruedInterestNet
48000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-69000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-574000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
427000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
48000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-280000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-221000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-170000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
276000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-19000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2754000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1165000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
300000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
9579000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9590000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
288000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18785000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1619000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4174000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
3027000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19930000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2199000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7586000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1322000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5889000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6053000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13475000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7375000
us-gaap Notes Issued1
NotesIssued1
112000
us-gaap Stock Issued1
StockIssued1
123000
mosy Fair Value Of Warrant Exercise Price Adjustment Considered As Deemed Dividend
FairValueOfWarrantExercisePriceAdjustmentConsideredAsDeemedDividend
392000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:3.71%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at </p> <p style="margin-top:10pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the date of the financial statements and the reported amounts of revenues and expenses recognized during the reported period.  Actual results could differ from those estimates.</span></p>
CY2021Q2 mosy Allowance For Doubtful Accounts As Percentage Of Invoice Value For Problematic Customer Balances Maximum
AllowanceForDoubtfulAccountsAsPercentageOfInvoiceValueForProblematicCustomerBalancesMaximum
1
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
41000000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
41000000
us-gaap Inventory Write Down
InventoryWriteDown
0
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
100000
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
The Company sells its products both directly to customers and through distributors generally under agreements with payment terms typically less than 60 days.
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
356000
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
23054000
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
23050000
CY2021Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2000000.0
CY2021Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
769000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
414000
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
257000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
185000
CY2021Q2 us-gaap Inventory Net
InventoryNet
1026000
CY2020Q4 us-gaap Inventory Net
InventoryNet
599000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
mosy Number Of Measurements Of Profitability
NumberOfMeasurementsOfProfitability
1
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1168000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1968000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2506000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3228000
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
64757
CY2021Q2 mosy Number Of Operating Leases Outstanding
NumberOfOperatingLeasesOutstanding
1
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1487601
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
5.00
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6800000
CY2021Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1818181
CY2021Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
7.15
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12000000.0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4174018
mosy Warrant To Purchase Of Common Stock
WarrantToPurchaseOfCommonStock
1739174
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.40
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
42672
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
139964
us-gaap Stock Issued1
StockIssued1
123066
mosy Gain Loss On Repayment Of Interest On Convertible Notes Payable
GainLossOnRepaymentOfInterestOnConvertibleNotesPayable
-16898
CY2021Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
613791000
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.40
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1473098
CY2021Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
1554173
CY2021Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.08
us-gaap Operating Lease Expense
OperatingLeaseExpense
100000
us-gaap Operating Lease Expense
OperatingLeaseExpense
100000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
113000
us-gaap Operating Lease Payments
OperatingLeasePayments
112000

Files In Submission

Name View Source Status
0001564590-21-043817-index-headers.html Edgar Link pending
0001564590-21-043817-index.html Edgar Link pending
0001564590-21-043817.txt Edgar Link pending
0001564590-21-043817-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mosy-10q_20210630.htm Edgar Link pending
mosy-10q_20210630_htm.xml Edgar Link completed
mosy-20210630.xsd Edgar Link pending
mosy-20210630_cal.xml Edgar Link unprocessable
mosy-20210630_def.xml Edgar Link unprocessable
mosy-20210630_lab.xml Edgar Link unprocessable
mosy-20210630_pre.xml Edgar Link unprocessable
mosy-ex311_7.htm Edgar Link pending
mosy-ex312_8.htm Edgar Link pending
mosy-ex321_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending